Andrew Fein
Stock Analyst at HC Wainwright & Co.
(4.53)
# 262
Out of 5,124 analysts
586
Total ratings
51.71%
Success rate
24.74%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMLX Amylyx Pharmaceuticals | Maintains: Buy | $16 → $20 | $12.08 | +65.56% | 21 | Nov 7, 2025 | |
| ALEC Alector | Maintains: Buy | $10 → $5 | $1.56 | +220.51% | 11 | Oct 22, 2025 | |
| UTHR United Therapeutics | Maintains: Buy | $400 → $500 | $487.25 | +2.62% | 17 | Sep 5, 2025 | |
| BIIB Biogen | Maintains: Buy | $187 → $194 | $175.99 | +10.23% | 22 | Aug 1, 2025 | |
| FULC Fulcrum Therapeutics | Upgrades: Buy | $4 → $12 | $11.31 | +6.10% | 18 | Jul 29, 2025 | |
| KALV KalVista Pharmaceuticals | Reiterates: Buy | $27 | $16.15 | +67.18% | 16 | Jul 11, 2025 | |
| CADL Candel Therapeutics | Assumes: Buy | $23 | $5.65 | +307.08% | 1 | Jun 30, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $54 → $60 | $77.81 | -22.89% | 8 | Jun 26, 2025 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $32 | $26.71 | +19.81% | 20 | Jun 26, 2025 | |
| VRTX Vertex Pharmaceuticals | Reiterates: Buy | $550 | $453.36 | +21.32% | 27 | Jun 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $174.04 | -31.05% | 15 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $6.51 | +22.89% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $6 → $2 | $6.03 | -66.83% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $35 | $34.49 | +1.48% | 14 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $14 | $9.55 | +46.60% | 18 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $35 | $31.74 | +10.27% | 14 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $14 | $5.02 | +178.88% | 16 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $69.55 | +7.84% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $68 | $72.13 | -5.73% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $19.56 | +94.27% | 12 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $25 | $20.36 | +22.79% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $32 | $16.51 | +93.82% | 22 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $7.80 | +284.62% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $16 | $19.17 | -16.54% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $24 | $11.86 | +102.36% | 19 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $3.14 | +282.17% | 16 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $104.67 | -63.70% | 6 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.98 | +304.04% | 2 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $168 | $141.83 | +18.45% | 20 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $11 | $2.11 | +421.33% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.35 | +643.49% | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $17.00 | +29.41% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $120 → $20 | $11.57 | +72.86% | 16 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $2.02 | +494.06% | 12 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $5.40 | +140.74% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $7.06 | +55.81% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $5.33 | +331.52% | 14 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.00 | +1,400.00% | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $90.00 | -5.56% | 16 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $23.34 | +49.96% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $8.14 | +821.38% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $41.52 | +80.64% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $1.91 | +266.49% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.23 | +348.43% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.59 | +25,497.27% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $200 → $60 | $13.96 | +329.95% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $5.18 | +189.58% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $0.85 | +4,589.33% | 3 | Mar 16, 2022 |
Amylyx Pharmaceuticals
Nov 7, 2025
Maintains: Buy
Price Target: $16 → $20
Current: $12.08
Upside: +65.56%
Alector
Oct 22, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $1.56
Upside: +220.51%
United Therapeutics
Sep 5, 2025
Maintains: Buy
Price Target: $400 → $500
Current: $487.25
Upside: +2.62%
Biogen
Aug 1, 2025
Maintains: Buy
Price Target: $187 → $194
Current: $175.99
Upside: +10.23%
Fulcrum Therapeutics
Jul 29, 2025
Upgrades: Buy
Price Target: $4 → $12
Current: $11.31
Upside: +6.10%
KalVista Pharmaceuticals
Jul 11, 2025
Reiterates: Buy
Price Target: $27
Current: $16.15
Upside: +67.18%
Candel Therapeutics
Jun 30, 2025
Assumes: Buy
Price Target: $23
Current: $5.65
Upside: +307.08%
Kymera Therapeutics
Jun 26, 2025
Maintains: Buy
Price Target: $54 → $60
Current: $77.81
Upside: -22.89%
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $32
Current: $26.71
Upside: +19.81%
Vertex Pharmaceuticals
Jun 23, 2025
Reiterates: Buy
Price Target: $550
Current: $453.36
Upside: +21.32%
Jun 11, 2025
Maintains: Buy
Price Target: $90 → $120
Current: $174.04
Upside: -31.05%
May 29, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $6.51
Upside: +22.89%
May 29, 2025
Downgrades: Neutral
Price Target: $6 → $2
Current: $6.03
Upside: -66.83%
May 28, 2025
Maintains: Buy
Price Target: $29 → $35
Current: $34.49
Upside: +1.48%
May 27, 2025
Maintains: Buy
Price Target: $30 → $14
Current: $9.55
Upside: +46.60%
May 14, 2025
Maintains: Buy
Price Target: $47 → $35
Current: $31.74
Upside: +10.27%
May 14, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $5.02
Upside: +178.88%
May 12, 2025
Maintains: Buy
Price Target: $80 → $75
Current: $69.55
Upside: +7.84%
May 12, 2025
Maintains: Buy
Price Target: $72 → $68
Current: $72.13
Upside: -5.73%
May 9, 2025
Maintains: Buy
Price Target: $46 → $38
Current: $19.56
Upside: +94.27%
May 8, 2025
Maintains: Buy
Price Target: $40 → $25
Current: $20.36
Upside: +22.79%
May 7, 2025
Maintains: Buy
Price Target: $80 → $32
Current: $16.51
Upside: +93.82%
May 6, 2025
Reiterates: Buy
Price Target: $30
Current: $7.80
Upside: +284.62%
May 5, 2025
Maintains: Buy
Price Target: $7 → $16
Current: $19.17
Upside: -16.54%
May 2, 2025
Maintains: Buy
Price Target: $81 → $24
Current: $11.86
Upside: +102.36%
May 1, 2025
Maintains: Buy
Price Target: $16 → $12
Current: $3.14
Upside: +282.17%
Apr 30, 2025
Reiterates: Buy
Price Target: $38
Current: $104.67
Upside: -63.70%
Apr 28, 2025
Reiterates: Buy
Price Target: $8
Current: $1.98
Upside: +304.04%
Apr 22, 2025
Maintains: Buy
Price Target: $185 → $168
Current: $141.83
Upside: +18.45%
Mar 28, 2025
Maintains: Buy
Price Target: $15 → $11
Current: $2.11
Upside: +421.33%
Mar 27, 2025
Reiterates: Buy
Price Target: $10
Current: $1.35
Upside: +643.49%
Mar 26, 2025
Reiterates: Buy
Price Target: $22
Current: $17.00
Upside: +29.41%
Mar 17, 2025
Downgrades: Neutral
Price Target: $120 → $20
Current: $11.57
Upside: +72.86%
Mar 14, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $2.02
Upside: +494.06%
Mar 7, 2025
Reiterates: Buy
Price Target: $13
Current: $5.40
Upside: +140.74%
Mar 6, 2025
Reiterates: Buy
Price Target: $11
Current: $7.06
Upside: +55.81%
Mar 6, 2025
Reiterates: Buy
Price Target: $23
Current: $5.33
Upside: +331.52%
Mar 6, 2025
Reiterates: Buy
Price Target: $15
Current: $1.00
Upside: +1,400.00%
Mar 3, 2025
Reiterates: Buy
Price Target: $85
Current: $90.00
Upside: -5.56%
Feb 28, 2025
Reiterates: Buy
Price Target: $35
Current: $23.34
Upside: +49.96%
Feb 18, 2025
Reiterates: Buy
Price Target: $75
Current: $8.14
Upside: +821.38%
Jan 13, 2025
Reiterates: Buy
Price Target: $75
Current: $41.52
Upside: +80.64%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $1.91
Upside: +266.49%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $2.23
Upside: +348.43%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $0.59
Upside: +25,497.27%
May 5, 2022
Downgrades: Neutral
Price Target: $200 → $60
Current: $13.96
Upside: +329.95%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $5.18
Upside: +189.58%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $0.85
Upside: +4,589.33%